Stay updated with breaking news from Tse Cph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipher Pharmaceuticals (TSE:CPH – Get Free Report) (NASDAQ:CPHR) will issue its quarterly earnings data after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of C$0.14 per share for the quarter. Cipher Pharmaceuticals (TSE:CPH – Get Free Report) (NASDAQ:CPHR) last issued its quarterly earnings data on Thursday, March 14th. The […]
Shares of Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) traded down 7.9% during trading on Monday . The stock traded as low as C$8.08 and last traded at C$8.20. 120,512 shares were traded during trading, an increase of 205% from the average session volume of 39,448 shares. The stock had previously closed at […]
Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as C$7.81 and last traded at C$7.73, with a volume of 44782 shares. The stock had previously closed at C$7.24. Analyst Ratings Changes Separately, Citigroup upped their price objective […]
Cipher Pharmaceuticals (TSE:CPH – Free Report) (NASDAQ:CPHR) had its target price boosted by Citigroup from C$4.75 to C$8.00 in a report published on Wednesday, BayStreet.CA reports. They currently have a buy rating on the stock. Cipher Pharmaceuticals Stock Performance Shares of TSE CPH opened at C$7.70 on Wednesday. The business’s 50-day moving average price is […]
Cipher Pharmaceuticals (TSE:CPH – Get Free Report) (NASDAQ:CPHR) had its target price lifted by research analysts at Citigroup from C$4.75 to C$8.00 in a research note issued to investors on Wednesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective points to a potential upside of 12.68% from the […]